Core Viewpoint - Qiagen (QGEN) has consistently beaten earnings estimates and is well-positioned for future earnings reports, particularly in the Zacks Medical - Biomedical and Genetics industry [1] Earnings Performance - For the most recent quarter, Qiagen reported earnings of $0.57 per share, exceeding the expected $0.54 per share, resulting in a surprise of 5.56% [2] - In the previous quarter, Qiagen's earnings were $0.55 per share against an expectation of $0.52 per share, leading to a surprise of 5.77% [2] Earnings Estimates and Predictions - There has been a favorable change in earnings estimates for Qiagen, with a positive Zacks Earnings ESP (Expected Surprise Prediction) indicating a strong likelihood of an earnings beat [4][7] - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [5] Earnings ESP Explanation - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [6] - Qiagen currently has an Earnings ESP of +2.95%, suggesting analysts are optimistic about the company's earnings prospects [7] Importance of Earnings ESP - Checking a company's Earnings ESP before quarterly releases is crucial for increasing the odds of success in predicting earnings performance [9]
Will Qiagen (QGEN) Beat Estimates Again in Its Next Earnings Report?